Whoop CEO Will Ahmed on Thursday said the wearable technology company’s blood pressure tool is a wellness use case that should not fall under the Food and Drug Administration’s jurisdiction for regulation.
Friday, November 7
By webmaster
Whoop CEO Will Ahmed on Thursday said the wearable technology company’s blood pressure tool is a wellness use case that should not fall under the Food and Drug Administration’s jurisdiction for regulation.
